Craig H. Mermel - Concepedia

Author

Craig H. Mermel

Also Known As

C. Mermel, Craig H Mermel, Craig H. Mermel, Craig Mermel, Lawrence, Michael S., Litjens G, Mermel, Craig, Peggy Bui, Yang, Ji-Yeon, S. Fisher

147

Publications

48.4K

Citations

H-Index

Concepts

All Affiliations

Broad Institute Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital Massachusetts General Hospital

About

Craig H. Mermel is an author at Broad Institute specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	14.8K
2	Engineering	5	5	1K
3	Health Sciences	2	2	794
4	Biomedical Engineering	2	2	367
5	Education	1	1	39

Craig H. Mermel

Publications

39.4K

Citations

H-Index

Page 1

	Year	Citations
Mutational heterogeneity in cancer and the search for new cancer-associated genes Michael S. Lawrence, Petar Stojanov, Paz Polak, Nature	2013	5.6K
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, New England Journal of Medicine	2014	4.5K
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 David A. Barbie, Pablo Tamayo, Jesse S. Boehm, Nature Systems BiologyOncogenic AgentMedicineKras-driven CancersCancer Biology	2009	4.1K
The landscape of somatic copy-number alteration across human cancers Rameen Beroukhim, Craig H. Mermel, Dale Porter, Nature Somatic VariantTumor HeterogeneityMedicinePathologySomatic Copy-number Alteration	2010	4K
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers Craig H. Mermel, Steven E. Schumacher, Barbara Hill, Genome biology	2011	3.7K
Discovery and saturation analysis of cancer genes across 21 tumour types Michael S. Lawrence, Petar Stojanov, Craig H. Mermel, Nature	2014	3.1K
Pan-cancer patterns of somatic copy number alteration Travis Zack, Steven E. Schumacher, Scott L. Carter, Nature Genetics	2013	2K
<i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer Jussi Koivunen, Craig H. Mermel, Kreshnik Zejnullahu, Clinical Cancer Research	2008	974
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Adam J. Bass, Hideo Watanabe, Craig H. Mermel, Nature Genetics Tumor BiologyOncogenic AgentMedicineAmplified Lineage-survival OncogenePathology	2009	944
Lin28 promotes transformation and is associated with advanced human malignancies Srinivas R. Viswanathan, John T. Powers, William S. Einhorn, Nature Genetics Tumor BiologyOncologyOncogenic AgentMedicinePathology	2009	814

Page 1